Bioxodes is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of therapeutics for patients with thrombo-inflammatory diseases. We leverage our deep understanding of the thrombotic and inflammatory processes to design novel product candidates with an aim to address unmet medical needs.
View Top Employees from BioxodesWebsite | http://www.bioxodes.com |
Revenue | $1 million |
Employees | 14 (14 on RocketReach) |
Founded | 2013 |
Phone | (327) 123-9600 |
Technologies |
JavaScript,
HTML,
Twitter
+10 more
(view full list)
|
Industry | Biotechnology, Manufacturing General, Pharmaceuticals, Manufacturing, Science and Engineering, Drug Discovery, Health Care, Therapeutics |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Bioxodes employee's phone or email?
The Bioxodes annual revenue was $1 million in 2024.
Hans-Christiaan Warrinnier is the Chief Medical Officer of Bioxodes.
14 people are employed at Bioxodes.
The NAICS codes for Bioxodes are [325, 32541, 32, 3254].
The SIC codes for Bioxodes are [283, 28].